indazoles has been researched along with aica ribonucleotide in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Jiang, W; Liu, S; Tang, Y; Yan, M | 1 |
1 other study(ies) available for indazoles and aica ribonucleotide
Article | Year |
---|---|
PIK3CA mutation sensitizes breast cancer cells to synergistic therapy of PI3K inhibition and AMPK activation.
Topics: Aminoimidazole Carboxamide; AMP-Activated Protein Kinases; Animals; Antineoplastic Agents; Breast Neoplasms; Cell Line, Tumor; Cell Survival; Class I Phosphatidylinositol 3-Kinases; Drug Synergism; Humans; Indazoles; Mice, Inbred BALB C; Mice, Nude; Mutation; Protein Kinase Inhibitors; Ribonucleotides; Sulfonamides | 2018 |